New cancer clinical trial: Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive
Published on: January 01, 2019
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Osimertinib
Sponsor: Fundación Grupo Español de Cáncer de Pulmón
Not yet recruiting
http://bit.ly/2LJf4zm Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Osimertinib
Sponsor: Fundación Grupo Español de Cáncer de Pulmón
Not yet recruiting
http://bit.ly/2LJf4zm Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive
Comments
Post a Comment